cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Novavax Inc
229 own
155 watching
Current Price
$4.28
$-0.02
(-0.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
663.58M
52-Week High
52-Week High
11.36000
52-Week Low
52-Week Low
3.53000
Average Volume
Average Volume
3.99M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization663.58M
icon52-Week High11.36000
icon52-Week Low3.53000
iconAverage Volume3.99M
iconDividend Yield--
iconP/E Ratio--
What does the Novavax Inc do?
Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Novavax Inc make?
News & Events about Novavax Inc.
CNBC: Business
10 months ago
The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5...
PR Newswire
10 months ago
Thinking about buying stock in Applied UV, CBAK Energy Technology, Novavax, C3.ai, or DBV Technologies? Thinking about buying stock in Applied UV, CBAK Energy Technology, Novavax, C3.ai, or DBV Technologies? PR Newswire NEW YORK, June 16, 2023 NEW YORK, June 16, 2023 /PRNewswire...
PR Newswire
10 months ago
Novavax Announces Adjournment of 2023 Annual Meeting of Stockholders to July 11, 2023 Novavax Announces Adjournment of 2023 Annual Meeting of Stockholders to July 11, 2023 PR Newswire GAITHERSBURG, Md., June 15, 2023 GAITHERSBURG, Md., June 15, 2023 /PRNewswire/ --Novavax, Inc. (Nasdaq: NVAX), a...
Stock Options Channel
11 months ago
Investors in Novavax, Inc. (NVAX) saw new options become available today, for the June 23rd expiration...
PR Newswire
11 months ago
Novavax to Host Conference Call to Discuss First Quarter 2023 Financial Results and Operational Highlights on May 9, 2023 Novavax to Host Conference Call to Discuss First Quarter 2023 Financial Results and Operational Highlights on May 9, 2023 PR Newswire GAITHERSBURG, Md., May 2, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Novavax Inc share price today?
plus_minus_icon
Can Indians buy Novavax Inc shares?
plus_minus_icon
How can I buy Novavax Inc shares from India?
plus_minus_icon
Can Fractional shares of Novavax Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Novavax Inc stocks?
plus_minus_icon
What is today’s traded volume of Novavax Inc?
plus_minus_icon
What is today’s market capitalisation of Novavax Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Novavax Inc?
plus_minus_icon
What percentage is Novavax Inc down from its 52-Week High?
plus_minus_icon
What percentage is Novavax Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.28
$-0.02
(-0.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00